612 results on '"Rocha, Flavio G."'
Search Results
2. A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion
3. Optimal Resource Allocation with Delay Guarantees for Network Slicing in Disaggregated RAN
4. ASO Visual Abstract: Prognostic Significance of Recurrence and Timing of Recurrence on Survival Among Patients with Early-Stage Hepatocellular Carcinoma in US Clinical Practice
5. Perioperative Chemotherapy for Pancreas Cancer: Quo Vadis?
6. ASO Visual Abstract: A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion
7. Reply to: Letter to Editor Entitled “Endoscopy’s Evolving Role in Locally Advanced and Borderline Resectable Pancreatic Cancer”
8. Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in surgical failure over two decades
9. Great Debates: Neoadjuvant Therapy Should be Routinely Given for High-Risk Cholangiocarcinoma
10. Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network
11. NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
12. Survival disparities in rural versus urban patients with pancreatic neuroendocrine tumor: A multi-institutional study from the US neuroendocrine tumor study group
13. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors
14. Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)
15. ASO Visual Abstract: Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy—An International Survey of the HAI Consortium Research Network
16. Hepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis
17. Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival in Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-analysis
18. Do Lymph Nodes Matter in Intrahepatic Cholangiocarcinoma?
19. Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations
20. Past, Present, and Future Management of Localized Biliary Tract Malignancies
21. Does Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis
22. ASO Visual Abstact: NEO-GAP: A Single-Arm, Phase II Feasibility Trial of Neoadjuvant Gemcitabine, Cisplatin, and Nab-paclitaxel for Resectable, High-Risk Intrahepatic Cholangiocarcinoma
23. Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network
24. Current Progress and Advances in Gastrointestinal Cancers: Highlights from the 2022 Annual American Society of Clinical Oncology (ASCO) Gastrointestinal Meeting
25. Neoadjuvant and Adjuvant Therapy for Cholangiocarcinoma
26. ASO Visual Abstract: Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors
27. ASO Visual Abstract: Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers – Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)
28. ASO Visual Abstract: Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival for Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis
29. Appendiceal Neuroendocrine Tumors: Does Colon Resection Improve Outcomes?
30. Impact of perioperative blood transfusion on survival in pancreatic neuroendocrine tumor patients: analysis from the US Neuroendocrine Study Group
31. Intraoperative radiation therapy in early-stage breast cancer: Presence of lobular features is not associated with increased rate of requiring additional therapy
32. Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts
33. Central pancreatectomy with pancreaticogastrostomy reconstruction: A brief report and video technique
34. Multimodal single-cell profiling reveals cancer crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients
35. Oncoplastic Breast-Conserving Surgery: Can We Reduce Rates of Mastectomy and Chemotherapy Use in Patients with Traditional Indications for Mastectomy?
36. Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer
37. ASO Visual Abstract: Does Caudate Resection Improve Outcomes inPatients Undergoing Curative Resection forPerihilar Cholangiocarcinoma? ASystematic Review and Meta-analysis
38. Early Recurrence Following Resection of Distal Cholangiocarcinoma: A New Tool for the Toolbox
39. Chapter 20 - Resection versus transplantation for intrahepatic and hilar cholangiocarcinoma
40. Specific Growth Rate as a Predictor of Survival in Pancreatic Neuroendocrine Tumors: A Multi-institutional Study from the United States Neuroendocrine Study Group
41. Evaluating Need for Additional Imaging and Biopsy After Oncoplastic Breast-Conserving Surgery
42. Primary and metastatic melanoma of the GI tract: clinical presentation, endoscopic findings, and patient outcomes
43. Impact of Insurance Status on Survival in Gastroenteropancreatic Neuroendocrine Tumors
44. Importance of Carbohydrate Antigen 19-9 Monitoring in the Management of Pancreatic Cancer
45. Staging and Prognosis
46. Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group
47. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management
48. Extreme oncoplasty: Expanding indications for breast conservation
49. Gastric carcinoids: Does type of surgery or tumor affect survival?
50. Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.